Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$60,663 | -$27,781 | -$72,902 | -$64,097 |
| Dep. & Amort. | $1,564 | $1,680 | $5,220 | $4,205 |
| Deferred Tax | $0 | $0 | $0 | -$9,261 |
| Stock-Based Comp. | $1,913 | $6,573 | $10,042 | $6,841 |
| Change in WC | -$1,321 | -$3,971 | -$1,942 | $149 |
| Other Non-Cash | $37,794 | $174 | $14,014 | $26,222 |
| Operating Cash Flow | -$20,713 | -$23,325 | -$45,568 | -$35,941 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$516 | -$281 | -$4,340 | -$2,247 |
| Net Acquisitions | $0 | $0 | $0 | -$11,714 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $367 | $0 | $0 |
| Other Inv. Act. | $4 | -$1,018 | $0 | $0 |
| Investing Cash Flow | -$512 | -$932 | -$4,340 | -$13,961 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$201 | -$117 | -$1,429 | -$1,534 |
| Stock Issued | $27,814 | $13,848 | $32,843 | $77,987 |
| Stock Repurch. | $0 | $0 | $0 | -$239 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$7,184 | -$1,545 | $4,392 | $2,150 |
| Financing Cash Flow | $20,429 | $12,186 | $35,806 | $78,364 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$796 | -$12,071 | -$14,102 | $28,462 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,132 | $23,203 | $37,305 | $8,843 |
| End Cash | $10,336 | $11,132 | $23,203 | $37,305 |
| Free Cash Flow | -$21,229 | -$23,606 | -$49,908 | -$38,188 |